¼Ã¢¿Á
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ³úÁ¾¾ç,À¯¹æ¾Ï,Ç÷¾×Á¾¾ç¾Ï,±âŸ¾Ï
Á÷
ˤ
:
ºñ°ø°³
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
5
ÇØ¿Ü
Byun HK, Yoon HI, Cho J, Shim KW, Han JW, Lyu CJ, Kim DS, Suh CO. Optimization of intracranial germinoma treatment: Radiotherapy alone with reduced volume and dose. Int J Radiat Oncol Biol Phys 2020 May 17:S0360-3016(20)31143-3. doi: 10.1016/j.ijrobp.2020.05.019. Online ahead of print.
4
ÇØ¿Ü
Choi J, Kim SH, Ahn SS, Choi HJ, Yoon HI, Cho JH, Roh TH, Kang SG, Chang JH, Suh CO. Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma. Sci Rep 2020;10(1):2086
3
ÇØ¿Ü
Lee DS, Lim DH, Kim IH, Kim JY, Han JW, Yoo KH, Park KD, Park HJ, Chung NG, Suh CO, Kim DS. Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma: Prospectvce multicenter cohort study. Radiother Oncol 2019;138:180-186
2
ÇØ¿Ü
Lee JJB, Lee J, Yoon HI, Kim SH, Cho J, Lee KS, Chang JH, Suh CO. Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma. J Neurooncol 2019;144(2):333-341
1
ÇØ¿Ü
Lee J, Yoon JS, Kim JS, Koom WS, Cho J, Suh CO. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization. Jpn J Clin Oncol 2019;49(7):664-670
1
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729